Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sheron Latcha

Showing results (1-10 of 28) with videos related to

Pageof 3
Sort By:
Seminars in Dialysis|March 21, 2019
Decision making for the initiation and termination of dialysis in patients with advanced cancerSheron Latcha
Seminars in Dialysis|October 10, 2019
Anemia management in cancer patients with chronic kidney diseaseSheron Latcha
Kidney360|February 14, 2024
Renal Salt Wasting Following CisplatinSheron Latcha, Shahzaib Chughtai
Kidney360|May 22, 2023
High-Cutoff Hemodialysis Therapy for Patients with Light Chain Cast Nephropathy and AKI Requiring Dialysis: PROSheron Latcha, Nelson Leung
Seminars in Nephrology|May 11, 2023
Rescue Therapies for AKI in Onconephrology: Rasburicase and GlucarpidaseSheron Latcha, Chintan V Shah
Advances in Chronic Kidney Disease|February 22, 2022
Cancer Screening in End-Stage Kidney DiseaseShayan Shirazian, Piotr Starakiewicz, Sheron Latcha
European Journal of Cancer (Oxford, England : 1990)|April 17, 2012
Long term renal toxicity of ifosfamide in adult patients--5 year dataJames K Farry, Carlos D Flombaum, Sheron Latcha
Kidney360|October 2, 2024
Kidney Disease in Systemic Amyloidosis: A Review of Amyloid, Amyloid Serum A Protein, Leukocyte Chemotactic Factor 2, and Transthyretin AmyloidRaad Chowdhury, Sujal Shah, Sheron Latcha, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|March 7, 2012
A retrospective observational study on the use of capecitabine in patients with severe renal impairment (GFR <30 mL/min) and end stage renal disease on hemodialysisKenar D Jhaveri, Carlos Flombaum, Manish Shah, et al.
Kidney International Reports|November 20, 2018
Case of Proteinuria, Worsening Hypertension, and Glomerular Endotheliosis With Erlotinib and GefitinibSheron Latcha, Edgar A Jaimes, Victoria Gutgarts, et al.
Pageof 3

Showing results (1-10 of 28) with videos related to

Sort By:
Pageof 3
Seminars in Dialysis|March 21, 2019
Decision making for the initiation and termination of dialysis in patients with advanced cancerSheron Latcha
Seminars in Dialysis|October 10, 2019
Anemia management in cancer patients with chronic kidney diseaseSheron Latcha
Kidney360|February 14, 2024
Renal Salt Wasting Following CisplatinSheron Latcha, Shahzaib Chughtai
Kidney360|May 22, 2023
High-Cutoff Hemodialysis Therapy for Patients with Light Chain Cast Nephropathy and AKI Requiring Dialysis: PROSheron Latcha, Nelson Leung
Seminars in Nephrology|May 11, 2023
Rescue Therapies for AKI in Onconephrology: Rasburicase and GlucarpidaseSheron Latcha, Chintan V Shah
Advances in Chronic Kidney Disease|February 22, 2022
Cancer Screening in End-Stage Kidney DiseaseShayan Shirazian, Piotr Starakiewicz, Sheron Latcha
European Journal of Cancer (Oxford, England : 1990)|April 17, 2012
Long term renal toxicity of ifosfamide in adult patients--5 year dataJames K Farry, Carlos D Flombaum, Sheron Latcha
Kidney360|October 2, 2024
Kidney Disease in Systemic Amyloidosis: A Review of Amyloid, Amyloid Serum A Protein, Leukocyte Chemotactic Factor 2, and Transthyretin AmyloidRaad Chowdhury, Sujal Shah, Sheron Latcha, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|March 7, 2012
A retrospective observational study on the use of capecitabine in patients with severe renal impairment (GFR <30 mL/min) and end stage renal disease on hemodialysisKenar D Jhaveri, Carlos Flombaum, Manish Shah, et al.
Kidney International Reports|November 20, 2018
Case of Proteinuria, Worsening Hypertension, and Glomerular Endotheliosis With Erlotinib and GefitinibSheron Latcha, Edgar A Jaimes, Victoria Gutgarts, et al.
Pageof 3